Author:
Soontrapa Nisarath,Rattanachaiyanont Manee,Warnnissorn Malee,Wongwananuruk Thanyarat,Indhavivadhana Suchada,Tanmahasamut Prasong,Techatraisak Kitirat,Angsuwathana Surasak
Abstract
AbstractWomen with chronic abnormal uterine bleeding-ovulatory dysfunction (AUB-O) are at increased risk of endometrial neoplasia. We conducted a non-inferiority randomized controlled trial to determine the effectiveness of two cyclic-progestin regimens orally administered 10 d/month for 6 months on endometrial protection and menstruation normalization in women with AUB-O. There were 104 premenopausal women with AUB-O randomized to desogestrel (DSG 150 µg/d, n = 50) or medroxyprogesterone acetate (MPA 10 mg/d, n = 54) group. Both groups were comparable in age (44.8 ± 5.7 vs. 42.5 ± 7.1 years), body mass index (24.8 ± 4.7 vs. 24.9 ± 4.7 kg/m2), and AUB characteristics (100% irregular periods). The primary outcome was endometrial response rate (the proportion of patients having complete pseudodecidualization in endometrial biopsies during treatment cycle-1). The secondary outcome was clinical response rate (the proportion of progestin withdrawal bleeding episodes with acceptable bleeding characteristics during treatment cycle-2 to cycle-6). DSG was not inferior to MPA regarding the endometrial protection (endometrial response rate of 78.0% vs. 70.4%, 95% CI of difference − 9.1–24.4%, non-inferiority limit of − 10%), but it was less effective regarding the menstruation normalization (acceptable bleeding rate of 90.0% vs 96.6%, P = 0.016).Clinical trial registration: ClinicalTrials.gov (NCT02103764, date of approval 18 Feb 2014).
Funder
Research and Development Fund of the Faculty of Medicine Siriraj Hospital
Publisher
Springer Science and Business Media LLC
Reference30 articles.
1. Munro, M. G., Critchley, H. O. D. & Fraser, I. S. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions. Int. J. Gynaecol. Obstet. 143, 393–408 (2018).
2. Fritz, M. A. Abnormal uterine bleeding. In Clinical Gynecologic Endocrinology and Infertility (eds Fritz, M. A. & Speroff, L.) 591–621 (Lippincott Williams & Wilkins, 2011).
3. Ferenczy, A. Pathophysiology of endometrial bleeding. Maturitas 45, 1–14 (2003).
4. Horbelt, D. V., Roberts, D. K., Parmley, T. H. & Walker, N. J. Ultrastructure of the microvasculature in human endometrial hyperplasia. Am. J. Obstet. Gynecol. 174, 174–183 (1996).
5. Abulafia, O. & Sherer, D. M. Angiogenesis of the endometrium. Obstet. Gynecol. 94, 148–153 (1999).